Advertisement
U.S. Markets closed
S&P Futures
5,875.25 +29.25 (+0.50%) Dow Futures
42,505.00 +184.00 (+0.43%) Nasdaq Futures
20,621.75 +123.00 (+0.60%) Russell 2000 Futures
2,232.00 +10.50 (+0.47%) Crude Oil
68.49 -3.29 (-4.58%) Gold
2,745.90 -8.70 (-0.32%)
Microbot Medical Inc. (MBOT)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
| Previous Close | 0.9602 |
| Open | 0.9600 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.9600 - 0.9990 |
| 52 Week Range | 0.8200 - 2.3500 |
| Volume | |
| Avg. Volume | 155,779 |
| Market Cap | 16.669M |
| Beta (5Y Monthly) | 1.64 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.7800 |
| Earnings Date | Nov 12, 2024 - Nov 18, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.00 |
ZacksMicrobot Medical Stock Rises After Completing ACCESS-PVI Trial
MBOT announces the successful completion of its ACCESS-PVI clinical trial for the LIBERTY Endovascular Robotic Surgical System, paving the way for FDA submission.
Medical Device NetworkMicrobot eyes FDA application for surgical robot after completing pivotal trial
The US robotics company is ramping up its go-to-market strategy ahead of potential US Food and Drug Administration (FDA) clearance in the second quarter of 2025 (Q2 2025).
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.